Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of Pegasys + placebo +
lamivudine versus lamivudine alone in patients with lamivudine versus lamivudine alone in
patients with hepatitis B antigen CHB.